Login / Signup

β-Adrenergic blockade in patients with dementia and hip fracture is associated with decreased postoperative mortality.

Ioannis IoannidisAhmad Mohammad IsmailMaximilian Peter ForsstenYang CaoGary Alan BassTomas BorgShahin Mohseni
Published in: European journal of trauma and emergency surgery : official publication of the European Trauma Society (2021)
Beta-blocker therapy is associated with decreased postoperative mortality in hip fracture patients with dementia up to 90 days after surgery. This finding warrants further investigation.
Keyphrases
  • hip fracture
  • mild cognitive impairment
  • patients undergoing
  • cardiovascular events
  • cognitive impairment
  • risk factors
  • type diabetes
  • stem cells
  • coronary artery disease
  • mesenchymal stem cells
  • cell therapy